Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias (AL)
Federica Galaverna(Bambino Gesù Children's Hospital), Swati Naik(St. Jude Children's Research Hospital), Eneida R. Nemecek(Oregon Health & Science University), Waseem Qasim(University College London), Pietro Merli(Children's Hospital of Philadelphia), Lakshmanan Krishnamurti(Emory University), Melissa Kuhn(Bellicum Pharmaceuticals (United States)), David A. Jacobsohn(Children's National), Annalisa Ruggeri(Inserm), Rajni Agarwal‐Hashmi(Stanford University), Victor Aquino(The University of Texas Southwestern Medical Center), Deepa Manwani(Albert Einstein College of Medicine), Neena Kapoor(University of Southern California), Franco Locatelli(Bambino Gesù Children's Hospital)
Cited by 2
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Sickle cell disease
|Nature Reviews Disease Primers|2018|1.4k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738